EMI (Encore Medical) Inventories, Raw Materials & Components: $0.23 Mil (As of Dec. 2025)


What is Encore Medical Inventories, Raw Materials & Components?

Encore Medical EMI Inventories, Raw Materials & Components is $0.23 Mil as of Dec. 2025.

Encore Medical's inventories, raw materials & components for the quarter that ended in Dec. 2025 was $0.23 Mil.

Encore Medical's quarterly raw materials increased from Jun. 2025 ($0.27 Mil) to Sep. 2025 ($0.29 Mil) but then declined from Sep. 2025 ($0.29 Mil) to Dec. 2025 ($0.23 Mil).

Encore Medical's annual raw materials declined from Dec. 2023 ($0.38 Mil) to Dec. 2024 ($0.21 Mil) but then increased from Dec. 2024 ($0.21 Mil) to Dec. 2025 ($0.23 Mil).

Encore Medical Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Encore Medical's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Inventories, Raw Materials & Components Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.38 0.21 0.23

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial 0.00 0.21 0.27 0.29 0.23

Encore Medical Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.23 Mil mean?
Encore Medical (EMI) has a Inventories, Raw Materials & Components of $0.23 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Encore Medical and its competitors.
Is Encore Medical's Inventories, Raw Materials & Components too high?
Encore Medical's current Inventories, Raw Materials & Components is $0.23 Mil.
How does Encore Medical's Inventories, Raw Materials & Components compare to ?
Encore Medical's Inventories, Raw Materials & Components of $0.23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Encore Medical and its competitors. Encore Medical's current Inventories, Raw Materials & Components is $0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Inventories, Raw Materials & Components of $0.23 Mil. The current Inventories, Raw Materials & Components is $0.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Encore Medical (EMI), the current Inventories, Raw Materials & Components is $0.23 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).